Publications 44 Datasets 392.5k Experiments 4.7k

Explore

44 matching publication(s)

Publication	Journal	Year	Score	Verdict
Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia. PMID 37620316	Nat Commun	2023	85	L1 85/100
Integrated multi-omics analysis combined with clinical validation reveals that HLA-DRB5 and ODAPH are causal risk genes for keratoconus. PMID 41803193	Sci Rep	2026	64	L1 64/100
Electroacupuncture reshapes the microbial co-occurrence networks related to the behavioral and psychological symptoms of dementia in Alzheimer's disease. PMID 41676443	IMetaOmics	2025	77	L1 77/100
Unveiling the immunometabolic landscape of colorectal cancer through PANoptosis-related gene expression. ⚑ PMID 41601652	Front Immunol	2026	41	L1 41/100 ⚑
Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma. PMID 41387425	Nat Commun	2025	66	L1 66/100
Advances in genomic and pharmacokinetic profiling for clinical stratification of metastatic breast cancer. PMID 41369820	Discov Oncol	2025	59	L1 59/100
Spatial-reprogramming derived GPNMB+ macrophages interact with COL6A3+ fibroblasts to enhance vascular fibrosis in PMID 41174767	Genome Med	2025	64	L1 64/100
Integration of multi-omics and machine learning strategies identifies immune related candidate biomarkers in inflammation-associated hypertrophic cardiomyopathy PMID 41080564	Front Immunol	2025	85	L1 85/100
Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation. PMID 41039608	Genome Med	2025	100	L1 100/100
Interpretable artificial intelligence based on immunoregulation-related genes predicts prognosis and immunotherapy response in lung adenocarcinoma. PMID 41048340	Front Bioinform	2025	71	L1 71/100
Positive Relationships between Intraocular Pressure and Thyroid Function in Graves' Ophthalmopathy: A Three-Aspect Evidence Analysis. PMID 40992768	Yonsei Med J	2025	68	L1 68/100
Targeted and personalized immunotherapy in lung adenocarcinoma: single-cell RNA sequencing of MAFF+ tumor cells and the therapeutic potential PMID 40936936	Front Immunol	2025	71	L1 71/100
Molecular subtype of recurrent implantation failure reveals distinct endometrial etiology of female infertility. PMID 40660214	J Transl Med	2025	68	L1 68/100
Gut-derived Lactobacillus from exceptional responders mitigates chemoradiotherapy-induced intestinal injury through methionine-driven epigene ⚑ PMID 40469520	Imeta	2025	89	L1 89/100 ⚑
Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer. PMID 40472802	EBioMedicine	2025	83	L1 83/100
Comprehensive bioinformatics analysis and experimental verification identify mitochondrial gene Dgat2 as a novel therapeutic biomarker for myocardial ischemia-r PMID 40510478	Front Endocrinol (Lausanne)	2025	64	L1 64/100
To Explore the Key Subgroup and Their Immune Microenvironment During the Formation of Coronary Plaque With scRNA-seq. ⚑ PMID 40454289	Cardiol Res Pract	2025	33	L2 33/100 ⚑
Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer. PMID 40197136	BMC Cancer	2025	59	L1 59/100
TGF-β-mediated activation of fibroblasts in cervical cancer: implications for tumor microenvironment and prognosis. PMID 40124621	PeerJ	2025	79	L1 79/100
A platelet-related signature for predicting the prognosis and immunotherapy benefit in bladder cancer based on machine learning combinations. ⚑ PMID 39280688	Transl Androl Urol	2024	51	L1 51/100 ⚑
Screening of Diagnostic Biomarkers and Immune Infiltration Characteristics Linking Rheumatoid Arthritis and Rosacea Based on Bioinformatics Analysis. ⚑ PMID 39104909	J Inflamm Res	2024	48	L1 48/100 ⚑
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). PMID 38897205	Cell Rep Med	2024	72	L1 72/100
Developing a novel immune infiltration-associated mitophagy prediction model for amyotrophic lateral sclerosis using bioinformatics strategies. PMID 38601155	Front Immunol	2024	71	L1 71/100
Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy. PMID 38504986	Front Immunol	2024	73	L1 73/100
Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid Leukemia Reveals a Signature Predicting Survival and Immunotherapy. PMID 38322112	Int J Clin Pract	2024	71	L1 71/100
Integrative analysis reveals chemokines CCL2 and CXCL5 mediated shear stress-induced aortic dissection formation. PMID 38163105	Heliyon	2023	75	L1 75/100
Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer. PMID 38076064	Heliyon	2023	71	L1 71/100
A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study. ⚑ PMID 37852185	Cell Rep Med	2023	65	65/100 ⚑
Zebrafish functional xenograft vasculature platform identifies PF-502 as a durable vasculature normalization drug. PMID 37680473	iScience	2023	70	L1 70/100
Identification of common genetic characteristics of rheumatoid arthritis and major depressive disorder by bioinformatics analysis and machine learning. ⚑ PMID 37415981	Front Immunol	2023	58	L1 58/100 ⚑
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells. PMID 37231145	NPJ Precis Oncol	2023	40	L1 40/100
Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma. PMID 37161060	Sci Rep	2023	73	L1 73/100
Specific signature biomarkers highlight the potential mechanisms of circulating neutrophils in aneurysmal subarachnoid hemorrhage. PMID 36438795	Front Pharmacol	2022	80	L1 80/100
Identification of intrinsic genes across general hypertension, hypertension with left ventricular remodeling, and uncontrolled hypertension. PMID 36277786	Front Cardiovasc Med	2022	73	L1 73/100
Artificial Intelligence Meets Whole Slide Images: Deep Learning Model Shapes an Immune-Hot Tumor and Guides Precision Therapy in Bladder Cancer. PMID 36245985	J Oncol	2022	—	not yet assessed
T Cells With Activated STAT4 Drive the High-Risk Rejection State to Renal Allograft Failure After Kidney Transplantation. PMID 35844542	Front Immunol	2022	78	L1 78/100
Identifying Molecular Subtypes and 6-Gene Prognostic Signature Based on Hypoxia for Optimizing Targeted Therapies in Non-Small Cell Lung Cancer. PMID 35509605	Int J Gen Med	2022	59	L1 59/100
Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer. ⚑ PMID 35311085	Front Oncol	2022	30	L1 30/100 ⚑
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma. PMID 34654806	Nat Commun	2021	100	L1 100/100
Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer. ⚑ PMID 33986754	Front Immunol	2021	51	L1 51/100 ⚑
Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma. PMID 33634984	Clin Transl Med	2021	85	L1 85/100
Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis. ⚑ PMID 33425745	Front Oncol	2020	48	L1 48/100 ⚑
Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx. PMID 33043022	Front Med (Lausanne)	2020	78	L1 78/100
Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. PMID 31443728	Genome Med	2019	68	L1 68/100